XWELL, Inc.

US$0.59As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:XWELHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (57.60%)
Div yield —
ROE (361.36%)
Diagnostics & Research
Beta (5Y) 1.09
PE TTM —
TSR TTM (33.43%)
Mkt cap US$5.055M
ROIC (403.18%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.746
26.74%
(79.38%)
Hold 1|8|12|2|4
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
(0.75%)
10.81%
10.27%
11.88%
Revenue$M
0.375
0.377
0.365
0.370
20.09%
14.10%
6.45%
4.25%
Peers (US$5.055M)
Cap (US$)
PE
2.051M
—
Capital
TTM
5Y
10Y
Leveragex
4.324
0.976
0.697
EBIT/Intx
5.619
2.953
2.780
Own earn%
(75.89)
(17.27)
(19.55)
Sh yield%
32.33
47.05
47.00
Owners
Insiders/Inst%
7.63
30.05
Short interest%
3.60
SBC / revenue%
2.62
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
10–16
$1 testx
—
Incr. ROIC%
12